C12N 2740/16334
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2740/16334 (Use of virus or viral component as vaccine) appears on 126 US grants and 199 published applications in this corpus.
Search patents in C12N- Granted patents
- 126
- Published applications
- 199
- Assignees
- 119
- Inventors
- 356
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 3 | 4 |
| 2003 | 2 | 9 |
| 2004 | 1 | 8 |
| 2005 | 1 | 15 |
| 2006 | 8 | 13 |
| 2007 | 2 | 9 |
| 2008 | 3 | 13 |
| 2009 | 5 | 11 |
| 2010 | 5 | 13 |
| 2011 | 3 | 8 |
| 2012 | 8 | 9 |
| 2013 | 7 | 5 |
| 2014 | 6 | 8 |
| 2015 | 10 | 8 |
| 2016 | 5 | 6 |
| 2017 | 12 | 14 |
| 2018 | 5 | 4 |
| 2019 | 4 | 7 |
| 2020 | 7 | 7 |
| 2021 | 3 | 5 |
| 2022 | 5 | 10 |
| 2023 | 4 | 3 |
| 2024 | 4 | 3 |
| 2025 | 1 | 5 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- HIV immunotherapy with no pre-immunization step18 Aug 2026US 12,709,753 B2American Gene Technologies International Inc.
- Infectious disease antigens and vaccines5 May 2026US 12,616,746 B2Seattle Project Corp.
- Compositions and methods for treating T cell exhaustion29 Jul 2025US 12,370,217 B2HTYR Acquisition LLC
- Alphavirus neoantigen vectors8 Oct 2024US 12,109,257 B2Gritstone Bio, Inc.
- HIV vaccines and methods of using6 Aug 2024US 12,053,517 B2Gilead Sciences, Inc.
- Nanoparticle compositions and uses thereof for reactivation of latent hiv27 Aug 2026US 2026/0248880 A1The Trustees of the University of Pennsylvania
- Vaccine comprising an antibody or an fc-containing fusion protein comprising an fc part of an antibody1 Jan 2026US 2026/0001939 A1Heidelberg ImmunoTherapeutics GmbH
- Compositions and methods for treating t cell exhaustion18 Dec 2025US 2025/0381226 A1HTYR Acquistion LLC
- Alphavirus antigen vectors7 Aug 2025US 2025/0249084 A1Gritstone Bio, Inc.
- Hiv vaccines and methods of using3 Apr 2025US 2025/0108104 A1Gilead Sciences, Inc.
Most cited
By later US patents
- Genetic immunization277US 5,593,972 AThe Trustees of the University of Pennsylvania · 1997
- Genetic immunization137US 5,817,637 AThe Trustees of the University of Pennsylvania · 1998
- Compositions and methods for delivery of genetic material132US 5,962,428 AApollon Inc. · 1999
- Genetic immunization117US 5,830,876 AThe Trustees of the University of Pennsylvania · 1998
- Viral vectors77US 5,650,309 AThe Regents of the University of California · 1997